(1 - 10 von 15
)
BioMarin, Merck, and Sanofi: The biggest news so far from 'JPM15' and...
www.biopharmadive.com
BioPharma
Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination...
www.merck.com
· the potential of MK for the treatment of cancer,” said Iain Dukes, senior vice president, Licensing and External Scientific Affairs, ...
Merck & Co licences late-stage psoriasis drug to Sun - PharmaTimes
www.pharmatimes.com
Merck & Co has decided not to carry on paying for the development of its late-stage psoriasis drug tildrakizumab, choosing instead to license the treatment to...
sortiert nach Relevanz / Datum